InvestorsHub Logo
Followers 6
Posts 355
Boards Moderated 0
Alias Born 12/30/2015

Re: None

Monday, 08/06/2018 6:47:00 PM

Monday, August 06, 2018 6:47:00 PM

Post# of 403106
SEE THE MATH - Billions $$ in market potential in less than a year possible for ELITE PHARMA!!!!!!!!

JUST 1% for the 2 approved puts ELITE at $5.3 MILLION, 5% = $26.5 MILLION. Revenue IS COMING!!!!!!!!

Approved - generic version of Percocet - QuintilesIMS Health data for the twelve months ending May 31, 2018, the retail sales for the brand and generic products were approximately $500 million.

APPROVED! - generic version of a synthetic narcotic analgesic - Based on QuintilesIMS Health data, the annual retail sales for the brand and generic products were approximately $30 million.

SOON! - generic version of Norco - $700 million according to IMS Health data.

SOON! - generic version of OxyContin - IMS reported approximately $2.3 billion in revenue for OxyContin® and its equivalents in 2016.

December 2018 (10 months) to Early 2019 - Elite/SunGen - generic version of an immediate release central nervous system (“CNS”) stimulant - IMS Health data, the branded product and its equivalents had total U.S. sales of more than $400 million for the twelve months ended September 30, 2017.

March 2019 (10 months) - Elite/SunGen - generic version of an extended release CNS stimulant - total U.S. sales of approximately $1.6 billion for the twelve months ended September 30, 2017.

$500 million + $700 Million + $30 million + $2.3 BILLION + $400 million + $1.6 BILLION = $5.44 BILLION market opening up to Elite (ELTP).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News